Will Oklo say “Cancer”?

Oklo did not say “Cancer” on its Aug 7, 2026 call (FY26 Q2); it said it on 3 of its last 8 calls: 1, 1, 2, 0, 0, 0, 0, 0 times. As of Oct 24, 2026, Oklo did not say “Cancer” on any of the 2 calls with a settled Kalshi mention market since Mar 17, 2026. Parrot’s p for the next listing is 18% (n=2, from settlement history blended with transcripts), not a forecast.

18%from settlement history blended with transcripts · n=2Next: Earnings call, Nov 10, 2026 · counts: company speakers + operator
Last 10
0/2Last 10 settled, oldest to newest: no no
Streak
not said the last 2 times
Counts
company speakers + operator
Market
47¢ Kalshi (may be delayed)
Updated

Where it was said

quotes of at most 25 words; select an appearance

Oklo

Cancer

Probability
18% · n=2
Settled
0/2 (0%)
Last calls
said in 3 of 8

Next listing counts: company speakers + operator

FY26 Q2 earnings call, Aug 7, 2026 · not said

Open the appearance

FY26 Q1 earnings call, May 12, 2026 · not said

Open the appearance

FY25 Q4 earnings call, Mar 17, 2026 · not said

Open the appearance

FY25 Q3 earnings call, Nov 11, 2025 · not said

Open the appearance

FY25 Q2 earnings call, Aug 11, 2025 · not said

Open the appearance

FY25 Q1 earnings call, May 13, 2025 · said 2 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

2 counted (2 in prepared remarks, 0 in Q&A).

Jake De WittecompanypreparedIn transcript

…domestic and vertically-integrated supply chain for high-value isotopes used in everything from cancer treatments and medical diagnostics to national security and advanced manufacturing. Their…

Jake De WittecompanypreparedIn transcript

…capabilities across medical, industrial, defense, and emerging tech sectors. From life-saving cancer therapies and diagnostic imaging to industrial sensors, aerospace applications, and advanced…

FY24 Q4 earnings call, Mar 24, 2025 · said 1 time (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

1 counted (1 in prepared remarks, 0 in Q&A).

Craig BealmearcompanypreparedIn transcript

…to exceed $55 billion by 2026, with applications spanning medical imaging, cancer therapies, space and defense, and next-generation semiconductor manufacturing. Meanwhile, aging facilities…

FY24 Q3 earnings call, Nov 14, 2024 · said 1 time (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

1 counted (1 in prepared remarks, 0 in Q&A).

Jake DewittecompanypreparedIn transcript

…are radioactive elements. They are vital materials with growing applications in cancer treatment, diagnostic imaging, space exploration, industrial processes and even advanced semiconductor…

Every settled listing

newest first · 2 shown
Every settled listing of this word, newest first
DateListed asVenueResultOur count
May 12, 2026CancerKalshiNo0
Mar 17, 2026CancerKalshiNo0

Questions

How many times did Oklo say “Cancer” on its last earnings call?
Oklo did not say “Cancer” on its Aug 7, 2026 call (FY26 Q2); it said it on 3 of its last 8 calls: 1, 1, 2, 0, 0, 0, 0, 0 times.
How often does Oklo say “Cancer”?
As of Oct 24, 2026, Oklo did not say “Cancer” on any of the 2 calls with a settled Kalshi mention market since Mar 17, 2026.
What is the probability Oklo says “Cancer” next time?
18%, from settlement history blended with transcripts (n=2). It is a base rate from history, not a forecast and not advice.
Who has to say it for the market to count?
Under the next market's rule: company speakers + operator.

Cite parrot.markets, “Oklo: ‘Cancer’ mention history”, as of Oct 24, 2026, https://parrot.markets/earnings/OKLO/words/cancer (CC BY 4.0)

Agents: this page as TSV at /api/v1/word?entity=oklo&word=cancer · quotes: /api/v1/quotes?entity=oklo&word=… · columnar JSON in #parrot-data · llms.txt · MCP